- Home
- PRGO vs MLTX Comparison
PRGO vs MLTX Comparison
Compare PRGO & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- MLTX
- Stock Information
- Founded
- PRGO 1887
- MLTX 2021
- Country
- PRGO Ireland
- MLTX Switzerland
- Employees
- PRGO N/A
- MLTX N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRGO Health Care
- MLTX Health Care
- Exchange
- PRGO Nasdaq
- MLTX Nasdaq
- Market Cap
- PRGO 3.9B
- MLTX 3.4B
- IPO Year
- PRGO 1991
- MLTX N/A
- Fundamental
- Price
- PRGO $26.40
- MLTX $56.16
- Analyst Decision
- PRGO Buy
- MLTX Strong Buy
- Analyst Count
- PRGO 4
- MLTX 9
- Target Price
- PRGO $37.00
- MLTX $77.43
- AVG Volume (30 Days)
- PRGO 1.2M
- MLTX 170.7K
- Earning Date
- PRGO 11-06-2024
- MLTX 11-07-2024
- Dividend Yield
- PRGO 4.16%
- MLTX N/A
- EPS Growth
- PRGO N/A
- MLTX N/A
- EPS
- PRGO N/A
- MLTX N/A
- Revenue
- PRGO $4,392,000,000.00
- MLTX N/A
- Revenue This Year
- PRGO N/A
- MLTX N/A
- Revenue Next Year
- PRGO $4.51
- MLTX N/A
- P/E Ratio
- PRGO N/A
- MLTX N/A
- Revenue Growth
- PRGO N/A
- MLTX N/A
- 52 Week Low
- PRGO $23.89
- MLTX $37.55
- 52 Week High
- PRGO $34.60
- MLTX $64.98
- Technical
- Relative Strength Index (RSI)
- PRGO 39.25
- MLTX 59.60
- Support Level
- PRGO $27.79
- MLTX $50.60
- Resistance Level
- PRGO $28.62
- MLTX $58.26
- Average True Range (ATR)
- PRGO 0.58
- MLTX 2.44
- MACD
- PRGO -0.29
- MLTX 0.11
- Stochastic Oscillator
- PRGO 6.04
- MLTX 72.58
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.